CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- 10-K Report Annual Report
- CT ORDER Other Confidential Order
- UPLOAD Other SEC-generated Letter
- SC 13D/A Stake Beneficial Ownership Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
Page 21 of 47 · 923 filings